leisure time -WSS

leisure time

author：leisure time 2025-09-27 09:39:59 - browse：3116

Element Biosciences exterior -- biotech coverage from STAT — Element Biosciences exterior Element Biosciences

SAN DIEGO — Companies racing to read the genome accurately, quickly, and affordably have hit a snag recently, with several firms reporting that their growth has slowed, stalled, or reversed. Upstart Element Biosciences is hoping it can succeed despite the challenging market conditions.

The San Diego firm launched a $290,000 sequencer, dubbed Aviti, in March 2022 and now has 150 instruments installed in more than 25 countries, according to a sales update Element shared with STAT. The modest growth comes at a time when some other players are struggling. Singular Genomics announced layoffs of 20% of its workforce earlier this year after the lackluster launch of its own sequencer. And Pacific Biosciences recently laid off nearly 200 employees after reporting disappointing first-quarter sales.

Element still has a long way to go in its bid to rival Illumina, a genomics giant that dominates 80% of the sequencing market and has more than 23,000 instruments in use around the world. That includes the NextSeq 2000, a $335,000 sequencer with a similar output to Aviti. Element is betting its blend of accuracy and a more moderate price point can help it carve out a niche of academic and biopharma customers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Cancer, immunology, HIV research ensnared in fetal tissue politics

focus

WSS

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Medicare Advantage insurers pressure Biden for bigger payments

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Google and Epic fight stronger regulation of AI in health care

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

Medical records are filled with copy

A public scorecard can help hold safety

Guidelines to prevent youth baseball injuries need more muscle

Biden tests positive for Covid

Trump demands the U.S. pay no more for drugs than other countries … again

WHO calls for emergency meeting on new China virus, as cases spread

Affirmative action in medical school literally saved lives

Sanofi seeks simpler, safer CRISPR sickle cell cure

The high cost of giving birth even with insurance

'Patient friction coefficient' can gauge a clinical trial's patient burden

leisure time

Cancer, immunology, HIV research ensnared in fetal tissue politics

Medical devices makers are asking for forgiveness, not permission

Cancer, immunology, HIV research ensnared in fetal tissue politics

Medicare to cover more brain scans for Alzheimer’s patients

This gene therapy has record $4.25 million price. It's saved children.

Medicare to cover more brain scans for Alzheimer’s patients

focus

focus

focus

leisure time